How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

REGN Jun 2024 1060.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.6000

+1.2000

(+85.71%)

As of 03:45PM EDT. Market open.

Loading interactive chart…

Simply Wall St.
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past five years
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
Investor's Business Daily
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Investor's Business Daily
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.